dc.contributor.author | Hatemi, Gülen | |
dc.contributor.author | YAZICI, Yılmaz | |
dc.contributor.author | OZGULER, Yeşim | |
dc.contributor.author | YAZICI, H | |
dc.date.accessioned | 2021-03-03T17:07:12Z | |
dc.date.available | 2021-03-03T17:07:12Z | |
dc.identifier.citation | YAZICI H., OZGULER Y., Hatemi G., YAZICI Y., "Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.", Arthritis care & research, cilt.68, ss.724, 2016 | |
dc.identifier.issn | 2151-464X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_48098c05-7baf-43f3-a76a-afa7c9adcf89 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/51943 | |
dc.identifier.uri | https://doi.org/10.1002/acr.22863 | |
dc.language.iso | eng | |
dc.title | Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al. | |
dc.type | Makale | |
dc.relation.journal | Arthritis care & research | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 68 | |
dc.identifier.startpage | 724 | |
dc.identifier.endpage | 724 | |
dc.contributor.firstauthorID | 159766 | |